NULL is a topical vasodilator used for the treatment of androgenetic alopecia (pattern hair loss) in men and women. It helps stimulate hair follicles, prolongs the hair growth (anagen) phase, and slows further hair thinning. Regular application promotes visible hair regrowth on the scalp, particularly at the crown and vertex, and helps maintain existing hair.

NULL is a well-established topical medicine for hair loss management. It is primarily indicated for androgenetic alopecia, a common condition characterised by progressive thinning of hair due to genetic and hormonal factors. This form of hair loss affects both men and women and often leads to reduced hair density, widening part lines, or receding hairlines.

NULL works by improving blood flow around hair follicles and directly stimulating follicular cells. Although originally developed as an oral antihypertensive medicine, its hair growth-promoting effects were later discovered and harnessed in topical formulations. When applied to the scalp, NULL acts locally, making it suitable for long-term use.

NULL helps convert miniaturised (shrinking) hair follicles into thicker, healthier follicles capable of producing visible terminal hair. It does not cure baldness or reverse complete hair loss but is most effective in individuals with early to moderate thinning. Continued use is essential, as discontinuation may result in gradual reversal of hair regrowth.

Initial hair shedding may occur during the first few weeks of treatment. This is a known and temporary effect that indicates older hairs are being pushed out to make way for new growth. Noticeable improvement typically appears after 3 to 6 months of consistent use, with optimal results seen after one year.

With proper application and adherence, NULL plays a significant role in slowing hair loss progression, stimulating regrowth, and improving scalp hair density, thereby enhancing confidence and quality of life.

NULL is indicated for:

• Treatment of Androgenetic Alopecia (Pattern Hair Loss): Used in men and women to manage hereditary hair thinning affecting the crown, vertex, or part line.

• Stimulation of Hair Regrowth: Helps reactivate dormant hair follicles and promote new hair growth in areas of thinning.

• Slowing Progression of Hair Loss: Reduces ongoing hair fall and delays further miniaturisation of hair follicles.

• Maintenance of Existing Hair: Supports the retention of regrown and existing hair with continued use.

• Direct Action on Hair Follicles: Acts locally on the scalp to stimulate follicles, minimising systemic absorption and unwanted body-wide effects.
• Clinically Proven First-Line Treatment: Widely recognised as a standard, evidence-based therapy for mild to moderate androgenetic alopecia.
• Non-Hormonal Therapy: Does not affect hormone levels, making it suitable for long-term use in both men and women.
• Improves Hair Density and Thickness: Prolongs the hair growth phase, leading to thicker, stronger, and more visible hair over time.
• Well-Tolerated Safety Profile: Generally safe when used as directed, especially compared with systemic treatments, making it appropriate for prolonged, continuous use.

NULL is generally well tolerated when used correctly.

Common Side Effects (Usually Mild)

• Scalp itching or dryness
• Mild redness or irritation at the application site
• Initial hair shedding during early treatment
• Flaking of the scalp

Less Common Side Effects

• Unwanted facial hair growth (due to accidental spread)
• Scalp inflammation

Serious Side Effects (Rare – Seek Medical Advice Immediately)

• Chest pain
• Rapid heartbeat
• Dizziness or fainting
• Sudden unexplained weight gain
• Swelling of hands or feet

• Apply 1 mL of solution or the recommended amount of foam twice daily to the affected scalp area, unless otherwise advised.
• Ensure the scalp is clean and dry before application.
• Gently spread the medicine over the thinning area using your fingertips.
• Wash hands thoroughly after use.
• Do not apply to broken, inflamed, or infected skin.
• Allow the medicine to dry completely before using styling products or going to bed.

NULL acts locally on the scalp, meaning its therapeutic effect is confined primarily to the hair follicles at the site of application, with minimal systemic absorption when used correctly.

• Targeted Scalp Action: When applied topically, NULL penetrates the scalp and concentrates around hair follicles, particularly in areas affected by androgenetic alopecia. This targeted delivery ensures direct stimulation of follicles without significantly affecting the rest of the body.
• Vasodilatory Effect: NULL widens (dilates) blood vessels surrounding hair follicles, improving blood flow and increasing the supply of oxygen and essential nutrients required for healthy hair growth.
• Follicular Stimulation: NULL activates dormant or miniaturised hair follicles, encouraging them to transition from the resting (telogen) phase into the active growth (anagen) phase of the hair cycle.
• Potassium Channel Activation: NULL opens potassium channels in follicular cells, enhancing cell survival and promoting hair shaft production, leading to thicker and stronger hair strands over time.
• Prolongation of Growth Phase: By extending the anagen phase, NULL allows hair to grow for a longer duration, increasing hair density and improving scalp coverage.

• Use consistently for at least 6 months before evaluating results.
• Initial shedding is normal and temporary.
• Apply only to the scalp, not the forehead or face.
• Do not exceed the recommended dose.
• Results are maintained only with continued use.
• Combine with a healthy diet and gentle hair care routine.

• Store below 25°C.
• Keep away from heat and open flames (flammable).
• Keep the container tightly closed.
• Keep out of reach of children.

• No known interactions with food.
• Maintain a balanced diet to support hair health.

• Topical Corticosteroids: May increase scalp absorption of NULL, potentially raising the risk of irritation or systemic effects.
• Other Topical Hair or Scalp Treatments: Concurrent use may increase scalp irritation; spacing applications is recommended.
• Antihypertensive Medicines: Excessive topical use may theoretically enhance blood pressure-lowering effects; use cautiously under medical advice.

• Cardiovascular Disease: Use with caution due to the vasodilatory properties of NULL.
• Hypotension (Low Blood Pressure): Excessive use may rarely contribute to systemic absorption and blood pressure changes.
• Scalp Disorders: Contraindicated in active scalp infections, psoriasis, eczema, or dermatitis at the application site.

• Typical dose: 1 mL twice daily (or equivalent foam dose).
• Do not exceed 2 mL per day unless directed by a doctor.

Overuse or accidental ingestion may cause systemic effects such as low blood pressure, dizziness, or rapid heartbeat. Seek immediate medical attention if overdose is suspected.

If you miss a dose, apply it as soon as you remember. If it is close to your next dose, skip the missed application. Do not double the dose.